Search Result "Ts1Cje."


The Akt-mTOR Pathway in Down’s Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 34-40
Author(s): Jose Antonio Troca-Marin,Juan Jose Casanas,Itziar Benito,Maria Luz Montesinos

Editorial (Thematic Issues: Pharmacological Intervention for Down Syndrome Cognitive Deficits: Emerging Drug Targets)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 6-7
Author(s): Maria Luz Montesinos

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome

Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 35-52
Author(s): Eric D. Hamlett,Heather A. Boger,Aurélie Ledreux,Christy M. Kelley,Elliott J. Mufson,Maria F. Falangola,David N. Guilfoyle,Ralph A. Nixon,David Patterson,Nathan Duval,Ann-Charlotte E. Granholm

Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2010 Page: 429-438
Author(s): Cristina Fillat, Mara Dierssen, Maria Martinez de Lagran, Xavier Altafaj

Editorial free to download

Editorial (Thematic Issue: The Link between Alzheimer’s Disease and Down Syndrome. A Historical Perspective)

Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 2-6
Author(s): Ahmad Salehi,J. Wesson Ashford,Elliott J. Mufson

Controlled Somatic and Germline Copy Number Variation in the Mouse Model

Journal: Current Genomics
Volume: 11 Issue: 6 Year: 2010 Page: 470-480
Author(s): Yann Herault, Arnaud Duchon, Damien Marechal, Matthieu Raveau, Patricia L. Pereira, Emilie Dalloneau, Veronique Brault

The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 16-25
Author(s): Alberto C.S. Costa

Review Article

Pharmacotherapy of Down’s Syndrome: When and Which?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18 Issue: 10 Year: 2019 Page: 750-757
Author(s): Seyed K. Tayebati,Alessandro Cecchi,Ilenia Martinelli,Elisa Carboni,Francesco Amenta

Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy

Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 68-83
Author(s): Cristy Phillips,Atoossa Fahimi,Devsmita Das,Fatemeh S. Mojabi,Ravikumar Ponnusamy,Ahmad Salehi

Mouse Models of Down Syndrome and Alzheimer’s Disease: Similarities and Differences

Ebook: Recent Advances in Alzheimer Research
Volume: 1 Year: 2015
Author(s): Noemí Rueda,Carmen Martínez-Cué
Doi: 10.2174/9781681081380115010013

Results 1 - 1 of 10

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy